{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T04:29:00Z","timestamp":1786768140262,"version":"build-2736575974"},"reference-count":11,"publisher":"Japanese Society of Internal Medicine","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,8,15]]},"DOI":"10.2169\/internalmedicine.6455-25","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T22:08:17Z","timestamp":1768428497000},"page":"2221-2225","source":"Crossref","is-referenced-by-count":0,"title":["Podocytic Infolding Gromerulopathy Developed at the Time of Transition from Chronic Myelogenous Leukemia to Myelodysplastic Syndrome"],"prefix":"10.2169","volume":"65","author":[{"given":"Aya","family":"Nakamori","sequence":"first","affiliation":[{"name":"Department of Nephrology, Otemae Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norimitsu","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Hematology, Otemae Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuyuko","family":"Akagaki","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Otemae Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Joh K, Taguchi T, Shigematsu H, et al. Proposal of podocytic infolding glomerulopathy as a new disease entity: a review of 25 cases from nationwide research in Japan. Clin Exp Nephrol 12: 421-431, 2008.","DOI":"10.1007\/s10157-008-0104-z"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Choung HYG, Jean-Gilles J, Goldman B. Subepithelial deposits with microspherular structures in membranous glomerulonephritis. Ultrastruct Pathol 46: 377-387, 2022.","DOI":"10.1080\/01913123.2022.2090646"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Feng Y, Wang W, Zou Y, et al. Podocyte infolding glomerulopathy: a case series report and literature review. J Clin Med 12: 1088, 2023.","DOI":"10.3390\/jcm12031088"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Schwotzer N, Provot F, Ville S, et al. Spectrum of kidney involvement in patients with myelodysplastic syndromes. Kidney Int Rep 6: 746-754, 2021.","DOI":"10.1016\/j.ekir.2020.12.030"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Lafargue MC, Huyen JPDV, Rennke HG, et al. Kidney involvement in myelodysplastic syndromes. Clin Kidney J 17: sfae185, 2024.","DOI":"10.1093\/ckj\/sfae185"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. d&apos;Izarny-Gargas T, Isnard P, Boudhabhay I, et al. The spectrum of glomerular and vascular kidney pathology associated with myeloproliferative neoplasms. Kidney Int 104: 1206-1218, 2023.","DOI":"10.1016\/j.kint.2023.09.010"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Haidary AM, Ahmed ZA, Abdul-Ghafar J, et al. Philadelphia chromosome positive chronic myeloid leukemia with 5q deletion at diagnosis. Mol Cytogenet 14: 16, 2021.","DOI":"10.1186\/s13039-021-00539-0"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Hosokawa K, Katagiri T, Sugimori N, et al. Favorable outcome of patients who have 13q deletion: a suggestion for revision of the WHO &apos;MDS-U&apos; designation. Haematologica 97: 1845-1849, 2012.","DOI":"10.3324\/haematol.2011.061127"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kandula P, Agarwal R. Proteinuria and hypertension with tyrosine kinase inhibitors. Kidney Int 80: 1271-1277, 2011.","DOI":"10.1038\/ki.2011.288"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Gayathri JS, Krishna SS, Rakesh MP. Tyrosine kinase inhibitor induced proteinuria - a review. Drug Res 75: 5-11, 2025.","DOI":"10.1055\/a-2423-3533"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Koinuma K, Sakairi T, Watanabe Y, et al. A case of long-term dasatinib-induced proteinuria and glomerular injury. CEN Case Rep 9: 359-364, 2020.","DOI":"10.1007\/s13730-020-00484-8"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/16\/65_6455-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T04:11:32Z","timestamp":1786767092000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/16\/65_6455-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,15]]},"references-count":11,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6455-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,15]]},"article-number":"6455-25"}}